Breaking News Instant updates and real-time market news.

CBI

CB&I

$9.78

-0.19 (-1.91%)

, FLR

Fluor

$37.77

-0.67 (-1.74%)

16:59
08/17/17
08/17
16:59
08/17/17
16:59

President Donald Trump shelves plans to create infrastructure advisory council

According to various media outlets, President Donald Trump has canceled plans to create an infrastructure advisory council. Companies in the sector include CB&I (CBI), Fluor (FLR), Aecom (ACM), MasTec (MTZ), Crown Castle (CCI), Jacobs Engineering (JEC) Martin Marietta (MLM) and U.S. Concrete (USCR).

CBI

CB&I

$9.78

-0.19 (-1.91%)

FLR

Fluor

$37.77

-0.67 (-1.74%)

ACM

Aecom

$31.09

-0.43 (-1.36%)

MTZ

MasTec

$39.20

0.45 (1.16%)

CCI

Crown Castle

$104.14

0.35 (0.34%)

JEC

Jacobs Engineering

$50.25

-0.8 (-1.57%)

MLM

Martin Marietta

$200.41

-4.7 (-2.29%)

USCR

U.S. Concrete

$77.20

-0.9 (-1.15%)

  • 11

    Sep

CBI CB&I
$9.78

-0.19 (-1.91%)

08/16/17
AGIS
08/16/17
NO CHANGE
Target $77
AGIS
Buy
W.R. Grace could rally $10 on CB&I unit acquisition, says Aegis
Aegis analyst Chris Kapsch believes Grace (GRA) is likely to become bigger via acquisitions and that CB&I's (CBI) process technology licensing division is a potential target. CB&I is a highly motivated seller, looking to complete the divestiture by year end, Kapsch tells investors in a research note. He believes Grace may be willing to pay as much as $1.5B for the asset and his "rough math" suggests such a deal could be 55c-60c accretive in FY18. This sort of deal accretion could be worth as much as $10 per share for Grace's equity, Kapsch argues. He has a Buy rating on Grace with a $77 price target.
08/16/17
JEFF
08/16/17
DOWNGRADE
Target $12
JEFF
Hold
CB&I downgraded to Hold from Buy at Jefferies
Jefferies analyst Martin Englert downgraded CB&I to Hold and cut his price target for the shares to $12 from $35. The analyst is concerned that cost overruns at the company's two LNG projects could reemerge, adding risk to 2017-2019 earnings.
08/11/17
FBCO
08/11/17
NO CHANGE
Target $13
FBCO
Neutral
CB&I price target lowered to $13 from $21 at Credit Suisse
Credit Suisse analyst Jamie Cook said that while CB&I's charges associated with Cameron and Freeport LNG and two gas fired power projects were expected, the $548M magnitude was bigger than expected. Also, unfortunately, since the two LNG projects are not expected to be complete until FY19, the market will "rightfully" remain concerned about potential additional charges, Cook tells investors. Cook lowered his FY17-19 estimates for CB&I and cut his price target on the stock to $13 from $21 while keeping a Neutral rating on the name.
08/16/17
08/16/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Dick's Sporting (DKS) was downgraded to Neutral from Buy at Monness Crespi, Goldman Sachs, MKM Partners, Buckingham, Citi, and to Neutral from Positive at Susquehanna, while being downgraded to Hold from Buy at Deutsche Bank and to Sector Perform from Outperform at RBC Capital. 2. Teva (TEVA) downgraded to Neutral from Buy at Citi with analyst Liav Abraham saying Teva is "cheap, but not cheap enough." 3. Advance Auto Parts (AAP) downgraded to Neutral from Overweight at Atlantic Equities with analyst Sam Hudson citing limited near-term visibility. 4. SL Green Realty (SLG) and Kilroy Realty (KRC) were downgraded to Neutral from Buy at BofA/Merrill, while Gramercy Property Trust (GPT) was downgraded to Underperform from Neutral. 5. CB&I (CBI) downgraded to Hold from Buy at Jefferies with analyst Martin Englert saying he is concerned that cost overruns at the company's two LNG projects could reemerge, adding risk to 2017-2019 earnings. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
FLR Fluor
$37.77

-0.67 (-1.74%)

08/04/17
08/04/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fluor (FLR) was downgraded to Hold from Buy at Deutsche Bank and to Neutral from Buy at DA Davidson. 2. Teva (TEVA) was downgraded to Market Perform from Outperform at Cowen, to Neutral from Outperform at Credit Suisse, and to Underperform from Outperform at RBC Capital. 3. Ford (F) downgraded to Neutral from Buy at Nomura Instinet with analyst Anindya Das citing uncertainties surrounding North America and European growth. 4. Avon Products (AVP) downgraded to Hold from Buy at Deutsche Bank with analyst Faiza Alwy saying the Chief Executive Officer change suggests that a business recovery, should there be one, is more than 12 months away. 5. CommScope (COMM) was downgraded to Hold from Buy at Cross Research, to Neutral from Buy at Longbow, and to Equal Weight from Overweight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/04/17
DBAB
08/04/17
DOWNGRADE
DBAB
Hold
Fluor downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Chad Dillard downgraded Fluor to Hold and lowered his price target for the shares to $40 from $55 citing execution concerns following last night's Q2 results. DA Davidson also downgraded the shares this morning.
08/04/17
DADA
08/04/17
DOWNGRADE
Target $48
DADA
Neutral
Fluor downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Brent Thielman downgraded Fluor to Neutral and cut his price target for the shares to $48 from $55. A recovery in the shares could take longer than expected following the "substantial"power project charges and "significant" reduction in backlog and bookings in Q2, Thielman tells investors in a post-earnings research note.
08/07/17
JRCO
08/07/17
DOWNGRADE
JRCO
Accumulate
Fluor downgraded to Accumulate from Buy at Johnson Rice
Johnson Rice downgraded Fluor to Accumulate and cut its price target to $48 from $62 following the Q2 report due to ongoing problem projects and limited visibility on the timing of new awards.
ACM Aecom
$31.09

-0.43 (-1.36%)

08/17/17
SBSH
08/17/17
NO CHANGE
Target $40
SBSH
Buy
Aecom is slowly gaining momentum, says Citi
After hosting meetings with management, Citi analyst Andrew Kaplowitz continues to believe Aecom "offers improving growth potential at a discounted valuation." The Q2 results "hinted" at the company's potential with strong free cash flow, Kaplowitz tells investors in a research note titled "ACM Slowly Gaining Momentum." The analyst keeps a Buy rating on the shares with a $40 price target.
06/29/17
FBCO
06/29/17
NO CHANGE
Target $44
FBCO
Outperform
Aecom COO change doesn't reflect operational issues, says Credit Suisse
Credit Suisse analyst Jamie Cook thinks the market will view the resignation of Stephen Kadenacy as COO at Aecom as a surprise given his recent promotion, but he does not believe it reflects any operational issues but instead is related to Kadenacy pursuing an opportunity with even greater responsibility and career advancement. Cook, who thinks replacement Randy Wotring will be a very capable COO, keeps an Outperform rating on Aecom shares.
06/26/17
UBSW
06/26/17
NO CHANGE
Target $38
UBSW
Buy
Aecom attractively valued with potential upcoming catalysts, says UBS
UBS analyst Steven Fisher believes shares of Aecom are attractively valued and sees several upcoming catalysts including the award of federal contracts, a ramp on higher margin revenues, and an acceleration of design and consulting revenue. The analyst reduced his earnings forecast to account for special items and thus reduced his price target to $38 from $43. Fisher reiterated his Buy rating on Aecom shares.
07/24/17
FBCO
07/24/17
DOWNGRADE
Target $37
FBCO
Neutral
Aecom downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Jamie Cook downgraded Aecom to Neutral and lowered its price target to $37 from $44 due to valuation and full expectations, and said the restructuring story has played out. Cook said the Trump infrastructure story has been pushed out and the Street is given Aecom full credit for its longer-term earnings growth goal of 10%, which provides little room for upside.
MTZ MasTec
$39.20

0.45 (1.16%)

08/17/17
STFL
08/17/17
NO CHANGE
STFL
MasTec has reached attractive entry point, says Stifel
Stifel analyst Noelle C. Dilts, noting that MasTec has declined 15% since August 3, believes that the stock has reached an attractive entry point. She thinks that investors are worried that the company's profit won;t increase next year, but she continues to believe that this will occur. After attending investor meetings with the company's head of IR, the analyst is confident that the company will have "a number of growth driver" next year and that it is currently " in the advanced stages of negotiating on a significant amount of large pipeline project work." Dilts thinks that the stock has reached an attractive entry point and keeps a Buy rating on the shares.
08/15/17
ADAM
08/15/17
NO CHANGE
Target $55
ADAM
Buy
MasTec pullback creates buying opportunity, says Canaccord
Canaccord analyst Bobby Burleson said diverse, strong fundamentals, and recent profit taking have created a surprisingly attractive entry point for MasTec shares. The analyst reminded investors he highlighted the company as a best idea coming out of the firm's growth conference and said the company remains upbeat about its prospects for growth for next year. Burleson reiterated his Buy rating and $55 price target on MasTec shares.
07/24/17
FBCO
07/24/17
UPGRADE
Target $55
FBCO
Outperform
MasTec upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Jamie Cook upgraded MasTec to Outperform and increased its price target to $55 from $46 saying there is increased evidence wireless & wireline spending should accelerate in FY18 and beyond and the O&G pipeline business should see better terms and pricing due to easing regulation and lack of increased capacity. Further, the analyst said Electric Transmission work is inflecting positively and turn profitable in FY17..
05/26/17
ADAM
05/26/17
NO CHANGE
Target $52
ADAM
Buy
MasTec weakness a buying opportunity, says Canaccord
Canaccord analyst Bobby Burleson said he sees a solid entry point for MasTec (MTZ) investors following its weakness in sympathy with Dycom (DY) shares after the latter provided soft guidance. The analyst noted MasTec's recently issue guidance builds in flat communications revenues with its growth to be driven by oil and gas. Burleson reiterated his Buy rating and $52 price target on MasTec shares.
CCI Crown Castle
$104.14

0.35 (0.34%)

06/08/17
DBAB
06/08/17
NO CHANGE
Target $118
DBAB
Buy
Crown Castle price target raised to $117 from $108 at Deutsche Bank
Deutsche Bank analyst Matthew Niknam raised his price target for Crown Castle to $117 saying the company is best positioned as an infrastructure "pure-play" on U.S. wireless traffic growth. After meeting with management, the analyst believes a "strong" pipeline and "multiple" catalysts reinforce his conviction. He keeps a Buy rating on Crown Castle shares.
06/12/17
RAJA
06/12/17
DOWNGRADE
RAJA
Market Perform
Crown Castle downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst Ric Prentiss downgraded Crown Castle to Market Perform citing strong year-to-date share performance and said consensus estimates now capture most of the benefit of the improving US leasing environment.
07/17/17
WELS
07/17/17
NO CHANGE
WELS
Outperform
Wells says Crown Castle $7B deal would provide attractive comp for Zayo
Wells Fargo analyst Jennifer Fritzsche noted the Reuters report that claims Crown Castle (CCI) has bid in the $7B range for Lightower Fiber Networks. She added the news is not surprising to her given how aggressive Crown Castle has been in building its fiber portfolio, which is a strategy with which she agrees. She believes such an acquisition would provide an attractive comp for Zayo Group (ZAYO), as she noted that Lightower is growing top line at a much faster rate but Zayo covers triple the geography. Fritzsche keeps Outperform ratings on Crown Castle and Zayo Group.
07/17/17
KEYB
07/17/17
NO CHANGE
Target $92
KEYB
Sector Weight
Crown Castle deal for Lightower likely negative for shares, says KeyBanc
KeyBanc analyst Brandon Nispel noted that Reuters reports Crown Castle has submitted a $7B bid to acquire Lightower Fiber Networks, a privately held fiber network provider in the U.S. He believes there is a level of investor skepticism toward the small cell business and that as Crown continues to acquire fiber providers that the stock is likely to see multiple compression. He keeps a Sector Weight rating and $92 fair value estimate on Crown Castle shares.
JEC Jacobs Engineering
$50.25

-0.8 (-1.57%)

08/03/17
SBSH
08/03/17
DOWNGRADE
Target $62
SBSH
Neutral
Jacobs Engineering downgraded to Neutral from Buy at Citi
Citi analyst Andrew Kaplowitz downgraded Jacobs Engineering to Neutral saying the price paid for CH2M is expensive and that the company's balance sheet is no longer a catalyst. The analyst lowered his price target for the shares to $62 from $66.
06/02/17
ARGS
06/02/17
NO CHANGE
ARGS
Jacobs Engineering weakness creates buying opportunity, says Argus
Argus analyst John Eade says that Jacobs is "showing signs of a turnaround" after the stock declined 3% over the last three months. He notes that the company reported better than expected Q2 results, and he thinks that it can benefit from infrastructure enhancement plans in the U.S., Canada, and Australia. The analyst recommends buying the shares.
02/22/17
ARGS
02/22/17
NO CHANGE
ARGS
Jacobs Engineering recent weakness creates buying opportunity, says Argus
Argus analyst John Eade says that Jacobs' stock has underperformed for the past two months, falling 2%. He says that the company's turnaround is continuing to progress, while it should benefit from the increased focus on infrastructure. The analyst keeps a Buy rating on the shares.
08/17/17
ARGS
08/17/17
NO CHANGE
ARGS
Jacobs Engineering weakness creates buying opportunity, says Argus
Argus analyst John Eade says that the underperformance by Jacobs over the past three months has created a buying opportunity. The analyst says that the company's performance is progressing, and he is upbeat about its turnaround strategy. Eade cut his price target on the shares to $62 from $72 and keeps a Buy rating on the stock.
MLM Martin Marietta
$200.41

-4.7 (-2.29%)

08/02/17
STFL
08/02/17
NO CHANGE
STFL
Martin Marietta Q2 miss creates buying opportunity, says Stifel
After Martin Marietta's Q2 results came in below expectations, Stifel analyst Stanley Elliott says the miss was "largely" caused by weather. The analyst expects the company's 2018 EBITDA to increase 20% excluding acquisitions and he thinks the stock's decline creates a buying opportunity.
06/29/17
LBOW
06/29/17
NO CHANGE
LBOW
Cement checks positive, says Longbow
After conducting a survey, Longbow analyst Garik Shmois says the "very strong" volume outlook supports his view that cement sales will jump by mid to high single digit percentage levels in 2H17. He keeps Buy ratings on CEMEX (CX), Martin Marietta (MLM), and Summit Materials (SUM). He keeps a Neutral rating on Eagle Materials (EXP).
03/31/17
CLVD
03/31/17
UPGRADE
CLVD
Buy
Martin Marietta upgraded to Buy from Neutral at Cleveland Research
Cleveland Research upgraded Martin Marietta to Buy following checks that indicate volumes are finishing the quarter much stronger than it started. The firm's analyst said visibility in backlogs implies accelerating growth through 2017 and into 2018 and pricing appears to be trending in-line with expectations.
03/29/17
SBSH
03/29/17
INITIATION
Target $245
SBSH
Buy
Martin Marietta initiated with a Buy at Citi
Citi analyst Scott Schrier started Martin Marietta Materials with a Buy rating and $245 price target. The analyst is "encouraged by the approaching ramp-up in infrastructure spending."
USCR U.S. Concrete
$77.20

-0.9 (-1.15%)

03/29/17
DADA
03/29/17
NO CHANGE
Target $80
DADA
Buy
U.S. Concrete recent weakness a buying opportunity, says DA Davidson
DA Davidson analyst Brent Thielman believes U.S. Concrete's recent disclosure of auditor change and the CFO resignation are unrelated and raises unnecessary concerns and said the move to big 4 independent auditor E&Y would not have occurred had there been a material concern by the firm. The analyst said U.S. Concrete has significant capital available to deploy and could attract a new DVO with more extensive M&A and/or materials industry experience and views the recent pullback as a buying opportunity. Thielman rates U.S. Concrete a Buy with an $80 price target.
05/05/17
DADA
05/05/17
NO CHANGE
DADA
U.S. Concrete reported 'blowout results,' says DA Davidson
DA Davidson analyst Brent Thielman says that U.S. Concrete reported "blowout" results. The analyst says that its "strategy of dominating share in local markets appears to be effective." He raised his price target on the stock to $85 from $80 and keeps a Buy rating on the shares.
06/21/17
RHCO
06/21/17
NO CHANGE
RHCO
U.S. Concrete EPS 'on track to double,' says SunTrust
SunTrust analyst Rohit Seth says that U.S. Concrete's EPS is 'on track to (at least) double over the next two years." Seth expects the company's Q2 results to beat expectations. The analyst calls the stock's valuation attractive and labels the shares "a compelling Buy."
08/09/17
SBSH
08/09/17
NO CHANGE
Target $92
SBSH
Buy
U.S. Concrete price target raised to $92 from $80 at Citi
Citi analyst Scott Schrier raised his price target for U.S. Concrete to $92 saying the company posted "another good quarter" with 8% organic volume growth. The analyst keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

BAC

Bank of America

$24.98

-0.185 (-0.74%)

, CME

CME Group

15:01
09/22/17
09/22
15:01
09/22/17
15:01
Hot Stocks
Bank of America broker-dealer affiliate ordered to pay $2.5M by CFTC »

The U.S. Commodity…

BAC

Bank of America

$24.98

-0.185 (-0.74%)

CME

CME Group

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FCAU

Fiat Chrysler

$17.96

0.59 (3.40%)

15:00
09/22/17
09/22
15:00
09/22/17
15:00
Options
$8.4M call buyer in Fiat Chrysler »

$8.4M call buyer in Fiat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$171.11

-1.06 (-0.62%)

14:53
09/22/17
09/22
14:53
09/22/17
14:53
Periodicals
Facebook settles lawsuit over non-voting shares, Business Insider reports »

Facebook settled a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

XOP

SPDR Oil Exploration and Production Fund

$33.00

0.09 (0.27%)

14:50
09/22/17
09/22
14:50
09/22/17
14:50
Options
SPDR Oil Exploration and Production ETF puts outpace calls 6:1 »

SPDR Oil Exploration and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTXI

GTx

$8.74

0.17 (1.98%)

14:48
09/22/17
09/22
14:48
09/22/17
14:48
Conference/Events
GTx, Inc to hold a KOL luncheon meeting »

Management hosts a KOL…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXPE

Expedia

$143.12

0.11 (0.08%)

14:45
09/22/17
09/22
14:45
09/22/17
14:45
Options
Expedia call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$74.21

-7.54 (-9.22%)

14:35
09/22/17
09/22
14:35
09/22/17
14:35
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPPI

Spectrum

$9.81

-0.13 (-1.31%)

14:27
09/22/17
09/22
14:27
09/22/17
14:27
Hot Stocks
Spectrum lower after Twitter highlights failed trial in Korea »

Shares of Spectrum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

DLPH

Delphi

$102.58

1.54 (1.52%)

14:21
09/22/17
09/22
14:21
09/22/17
14:21
Conference/Events
Delphi to hold investor update meeting »

Investor Update Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

$NSD

NASDAQ Market Internals

14:17
09/22/17
09/22
14:17
09/22/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
09/22/17
09/22
14:16
09/22/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$117.03

0.56 (0.48%)

14:15
09/22/17
09/22
14:15
09/22/17
14:15
Options
Chevron put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 09

    Nov

S

Sprint

$8.42

0.39 (4.86%)

, TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

14:12
09/22/17
09/22
14:12
09/22/17
14:12
Periodicals
Sprint hired lobbyist tied to Trump in September, Reuters says »

Sprint (S) hired a…

S

Sprint

$8.42

0.39 (4.86%)

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

OPK

OPKO Health

$6.48

0.15 (2.37%)

14:05
09/22/17
09/22
14:05
09/22/17
14:05
Options
Opko Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

14:05
09/22/17
09/22
14:05
09/22/17
14:05
General news
Dallas Fed hawk Kaplan is open minded about one more hike »

Dallas Fed hawk Kaplan is…

GWRE

Guidewire

$78.42

1.26 (1.63%)

14:04
09/22/17
09/22
14:04
09/22/17
14:04
Conference/Events
Guidewire to host analyst day »

Analyst Day to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCPT

Four Corners Property Trust

$25.05

-0.27 (-1.07%)

, WPG

Washington Prime

$8.13

0.095 (1.18%)

14:02
09/22/17
09/22
14:02
09/22/17
14:02
Recommendations
Four Corners Property Trust, Washington Prime analyst commentary  »

Four Corners Property…

FCPT

Four Corners Property Trust

$25.05

-0.27 (-1.07%)

WPG

Washington Prime

$8.13

0.095 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$61.75

-0.76 (-1.22%)

, UNH

UnitedHealth

$188.70

-6.51 (-3.33%)

14:02
09/22/17
09/22
14:02
09/22/17
14:02
Hot Stocks
Health insurers jump as McCain comes out against latest repeal/replace effort »

Shares of a number of…

MOH

Molina Healthcare

$61.75

-0.76 (-1.22%)

UNH

UnitedHealth

$188.70

-6.51 (-3.33%)

CNC

Centene

$87.58

-3.16 (-3.48%)

WCG

WellCare

$163.07

-2.99 (-1.80%)

CI

Cigna

$181.14

-0.99 (-0.54%)

ANTM

Anthem

$181.21

-2.29 (-1.25%)

HNT

Health Net

HUM

Humana

$235.79

-2.85 (-1.19%)

AET

Aetna

$150.76

-2.63 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

ICPT

Intercept

$73.70

-24.42 (-24.89%)

13:57
09/22/17
09/22
13:57
09/22/17
13:57
Downgrade
Intercept rating change  »

Oppenheimer downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$46.29

0.87 (1.92%)

13:57
09/22/17
09/22
13:57
09/22/17
13:57
Hot Stocks
Trump thanks American Airlines for 'fantastic job' with hurricane flights »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

IWM

iShares Trust Russell 2000 Index Fund

$144.38

0.69 (0.48%)

, RUT

Russell 2000 Index

13:53
09/22/17
09/22
13:53
09/22/17
13:53
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT) is…

IWM

iShares Trust Russell 2000 Index Fund

$144.38

0.69 (0.48%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$61.77

-0.74 (-1.18%)

, UNH

UnitedHealth

$189.08

-6.13 (-3.14%)

13:53
09/22/17
09/22
13:53
09/22/17
13:53
Periodicals
McCain says cannot vote for Graham-Cassidy healthcare bill, Bloomberg reports »

Publicly traded companies…

MOH

Molina Healthcare

$61.77

-0.74 (-1.18%)

UNH

UnitedHealth

$189.08

-6.13 (-3.14%)

CNC

Centene

$87.61

-3.13 (-3.45%)

WCG

WellCare

$162.70

-3.36 (-2.02%)

CI

Cigna

$181.18

-0.9483 (-0.52%)

ANTM

Anthem

$181.24

-2.26 (-1.23%)

HNT

Health Net

HUM

Humana

$235.91

-2.735 (-1.15%)

AET

Aetna

$150.81

-2.58 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

XLE

Energy Select Sector SPDR

$67.08

0.22 (0.33%)

, XLI

Industrial Select Sector SPDR

$70.76

0.19 (0.27%)

13:51
09/22/17
09/22
13:51
09/22/17
13:51
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

For the week, the S&P…

XLE

Energy Select Sector SPDR

$67.08

0.22 (0.33%)

XLI

Industrial Select Sector SPDR

$70.76

0.19 (0.27%)

XLF

Financial Select Sector

$25.43

-0.035 (-0.14%)

XLB

S&P Select Materials SPDR

$56.57

-0.18 (-0.32%)

XLP

Consumer Staples Sector SPDR

$53.97

-0.115 (-0.21%)

XLU

Utilities SPDR

$53.43

-0.24 (-0.45%)

XLV

Health Care Select Sector SPDR

$81.25

-0.33 (-0.40%)

SPY

SPDR S&P 500 ETF Trust

$249.16

-0.23 (-0.09%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$54.07

0.16 (0.30%)

, UGI

UGI Corporation

$47.06

-0.28 (-0.59%)

13:50
09/22/17
09/22
13:50
09/22/17
13:50
Periodicals
Total sells Total Italia Gas to UGI Corporation, Reuters reports »

Total (TOT) has sold its…

TOT

Total

$54.07

0.16 (0.30%)

UGI

UGI Corporation

$47.06

-0.28 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$21.56

0.3975 (1.88%)

13:50
09/22/17
09/22
13:50
09/22/17
13:50
Options
One-week option play opened in Macy's »

One-week option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.